Trial intelligence / Profile preview

Safety and Immunogenicity of LJEV and Measles Vaccine Co-administration in Sri Lankan Children

NCT00463684Phase 4Completed

Sponsor
PATH
Start
Jul 2007
Primary completion
Nov 2007
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of japanese encephalitis vaccine sa14-14-2 in Japanese encephalitis (JE), sponsored by PATH. Started Jul 2007; status: completed.

02

Drugs

japanese encephalitis vaccine sa14-14-2
03

Conditions

Japanese encephalitis (JE)

Beyond the preview

Go deeper on NCT00463684.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00463684.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call